Safety Study of Dasatinib With Bortezomib (Velcade®) and Dexamethasone for Multiple Myeloma

Clinical trial NCT00560352 · TERMINATED

Trial details

NCT number: NCT00560352
Sponsor: Bristol-Myers Squibb
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Multiple Myeloma

Start date: 2008-02-01
Primary completion: 2011-02-01
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.